Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christian Behrenbruch Insider Profile
4 Followers
Christian Behrenbruch, Director at Amplia Therapeutics Ltd., holds 23.23M shares in Telix Pharmaceuticals Ltd. (Ticker: TLPPF), holds 2.74M shares in Amplia Therapeutics Ltd. (Ticker: INNMF).
Christian Behrenbruch Amplia Therapeutics Ltd. (INNMF)Director
Amplia Therapeutics Ltd. (INNMF)
Director
Ranked #27,819 out of 100,202 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+66.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Christian Behrenbruch holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 17, 2019 - Sep 17, 2020
Return:+133.30%
The most profitable trade made by Christian Behrenbruch
Christian Behrenbruch's Trading History
Amplia Therapeutics Ltd.
Sep 17, 2019
Director
Informative Buy
25.00K
$164.53K
Telix Pharmaceuticals Ltd.
Jan 22, 2024
Managing Director & Chief Executive Officer
Uninformative Sell
―
$369.33M
List of latest transactions for each holding click on a transaction to see Christian Behrenbruch's performance on stock
You May Also Like
Christian Behrenbruch insider profile FAQ
What is the percentage of profitable transactions made by Christian Behrenbruch?
The percentage of profitable transactions made by Christian Behrenbruch is 50%.
What is the average return per transaction made by Christian Behrenbruch?
The average return per transaction made by Christian Behrenbruch is 66.10%.
What stocks does Christian Behrenbruch hold?
Christian Behrenbruch holds: INNMF, TLPPF stocks.
What was Christian Behrenbruch’s latest transaction?
Christian Behrenbruch latest transaction was an Uninformative Sell of ―.
What was Christian Behrenbruch's most profitable transaction?
Christian Behrenbruch’s most profitable transaction was an Informative Buy of INNMF stock on September 17, 2019. The return on the trade was 133.30%.
What is Christian Behrenbruch's role in Amplia Therapeutics Ltd.?
Christian Behrenbruch's role in Amplia Therapeutics Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.